132 related articles for article (PubMed ID: 16414330)
1. Vasomotor symptom relief versus unwanted effects: role of estrogen dosage.
Ettinger B
Am J Med; 2005 Dec; 118 Suppl 12B():74-8. PubMed ID: 16414330
[TBL] [Abstract][Full Text] [Related]
2. Rationale for use of lower estrogen doses for postmenopausal hormone therapy.
Ettinger B
Maturitas; 2007 May; 57(1):81-4. PubMed ID: 17383126
[TBL] [Abstract][Full Text] [Related]
3. Low-dose estrogen therapy for menopausal women: a review of efficacy and safety.
Crandall C
J Womens Health (Larchmt); 2003 Oct; 12(8):723-47. PubMed ID: 14588124
[TBL] [Abstract][Full Text] [Related]
4. Moderate dosage estrogen-androgen therapy improves continuation rates in postmenopausal women: impact of the WHI reports.
Gambrell RD; Natrajan PK
Climacteric; 2006 Jun; 9(3):224-33. PubMed ID: 16766436
[TBL] [Abstract][Full Text] [Related]
5. Estrogens and progestins: background and history, trends in use, and guidelines and regimens approved by the US Food and Drug Administration.
Stefanick ML
Am J Med; 2005 Dec; 118 Suppl 12B():64-73. PubMed ID: 16414329
[TBL] [Abstract][Full Text] [Related]
6. Menopause and stroke and the effects of hormonal therapy.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():27-31. PubMed ID: 17882669
[TBL] [Abstract][Full Text] [Related]
7. Effects of low-dose hormone therapy on menopausal symptoms, bone mineral density, endometrium, and the cardiovascular system: a review of randomized clinical trials.
Peeyananjarassri K; Baber R
Climacteric; 2005 Mar; 8(1):13-23. PubMed ID: 15804728
[TBL] [Abstract][Full Text] [Related]
8. Estrogen with and without progestin: benefits and risks of short-term use.
LaCroix AZ
Am J Med; 2005 Dec; 118 Suppl 12B():79-87. PubMed ID: 16414331
[TBL] [Abstract][Full Text] [Related]
9. Options for hormone therapy in women who have had a hysterectomy.
Haney AF; Wild RA
Menopause; 2007; 14(3 Pt 2):592-7; quiz 598-9. PubMed ID: 17476150
[TBL] [Abstract][Full Text] [Related]
10. Changing use of hormone therapy among minority women since the Women's Health Initiative.
Helenius IM; Korenstein D; Halm EA
Menopause; 2007; 14(2):216-22. PubMed ID: 17179789
[TBL] [Abstract][Full Text] [Related]
11. Hormone therapy and breast cancer risk.
Foidart JM; Desreux J; Pintiaux A; Gompel A
Climacteric; 2007 Oct; 10 Suppl 2():54-61. PubMed ID: 17882674
[TBL] [Abstract][Full Text] [Related]
12. Vaginal, endometrial, and reproductive hormone findings: randomized, placebo-controlled trial of black cohosh, multibotanical herbs, and dietary soy for vasomotor symptoms: the Herbal Alternatives for Menopause (HALT) Study.
Reed SD; Newton KM; LaCroix AZ; Grothaus LC; Grieco VS; Ehrlich K
Menopause; 2008; 15(1):51-8. PubMed ID: 18257142
[TBL] [Abstract][Full Text] [Related]
13. Postmenopausal hormones and coronary artery disease: potential benefits and risks.
Lobo RA
Climacteric; 2007 Oct; 10 Suppl 2():21-6. PubMed ID: 17882668
[TBL] [Abstract][Full Text] [Related]
14. Invited Commentary: Hormone therapy risks and benefits--The Women's Health Initiative findings and the postmenopausal estrogen timing hypothesis.
Banks E; Canfell K
Am J Epidemiol; 2009 Jul; 170(1):24-8. PubMed ID: 19468078
[TBL] [Abstract][Full Text] [Related]
15. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
Rossouw JE
Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
[TBL] [Abstract][Full Text] [Related]
16. Influence of hormone replacement therapy on tamoxifen-induced vasomotor symptoms.
Sestak I; Kealy R; Edwards R; Forbes J; Cuzick J
J Clin Oncol; 2006 Aug; 24(24):3991-6. PubMed ID: 16921052
[TBL] [Abstract][Full Text] [Related]
17. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy?
Greendale GA; Gold EB
Am J Med; 2005 Dec; 118 Suppl 12B():148-54. PubMed ID: 16414341
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and tolerability of continuous combined hormone replacement therapy in early postmenopausal women.
Mattsson LA; Skouby S; Rees M; Heikkinen J; Kudela M; Stadnicki-Kolendo A; Mattila L; Salminen K; Vuorela A; Mustonen M;
Menopause Int; 2007 Sep; 13(3):124-31. PubMed ID: 17785038
[TBL] [Abstract][Full Text] [Related]
19. Is there a place for postmenopausal hormone therapy use in women with lupus?
Gompel A; Piette JC
Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a new, oral estradiol acetate formulation for relief of menopause symptoms.
Speroff L; Haney AF; Gilbert RD; Ellman H;
Menopause; 2006; 13(3):442-50. PubMed ID: 16735941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
